Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

Albert Bourla and other healthcare CEOs talked about the efficacy of vaccines and how public health could take a big turn for ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.

At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...

Only 23 countries use climate data for health surveillance, says head of WMO, adding more collaboration needed ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...